Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Philip A. Sharp currently holds 238,833 shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Philip A. Sharp has been a net seller of ALNY stock. They have purchased $200.0K and sold $30.7M worth of shares.
Philip A. Sharp's most recent insider trade was on Apr 15, 2019, when they sold 11,800 shares at $87.86 per share.
Philip A. Sharp serves as Executive at ALNYLAM PHARMACEUTICALS, INC. (ALNY). They have executed 122 insider transactions totaling $30.9M over their tenure at the company.
Philip A. Sharp holds the position of Executive at ALNYLAM PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Philip A. Sharp has shown a selling trading pattern, with $200.0K in total purchases and $30.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Philip A. Sharp was on Oct 13, 2014, when they sold $9.3M worth of ALNY shares. This transaction involved 110,000 shares at $85.00 per share.
Philip A. Sharp currently owns 238,833 shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Philip A. Sharp's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Philip A. Sharp has 122 Form 4 filings on record as an insider at ALNYLAM PHARMACEUTICALS, INC..
Set alerts for Philip A. Sharp and 40,000+ other insiders.